Digitalis purpurea" extract containing cardiac glycosides for the treatment of heart conditions was first described in the English-speaking medical literature by William Withering, in 1785, which is considered the beginning of modern therapeutics. It is used to increase cardiac contractility (it is a positive inotrope) and as an antiarrhythmic agent to control the heart rate, particularly in the irregular (and often fast) atrial fibrillation. Digitalis is hence often prescribed for patients in atrial fibrillation, especially if they have been diagnosed with congestive heart failure. Digoxin was approved for heart failure in 1998 under current regulations by the Food and Drug Administration
We Do What We Want We Do What We Want We Do What We Want is the fifth studio album by the American rock band Emery. The album was released on March 29, 2011 through Tooth & Nail Records and Solid State Records. Shortly after announcing the release of "We Do What We Want", founding bassist Devin Shelton announced he would be taking an indefinite hiatus from Emery. Emery was in the process of working on more stripped-down acoustic album when guitarist/vocalist Devin Shelton decided to take an indefinite leave of absence from the group. After his departure, the remaining four members made the conscious